BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23760149)

  • 21. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years.
    Sykes PH; Simcock BJ; Innes CR; Harker D; Williman JA; Whitehead M; van der Griend RA; Lawton BA; Hibma M; Fitzgerald P; Dudley NM; Petrich S; Eva L; Bergzoll C; Kathuria J; McPherson G; Tristram A; Faherty J; Hardie D; Robertson A; Robertson V; Pather S; Wrede CD; Gastrell F; Fentiman G; John M; White E; Parker C; Sadler L
    Am J Obstet Gynecol; 2022 Feb; 226(2):222.e1-222.e13. PubMed ID: 34534506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The incidence of cervical intraepithelial neoplasia in a population of pregnant women with an abnormal cytology.
    Pruski D; Malkowska-Walczak B; Paluszkiewicz A; Kędzia W
    Ginekol Pol; 2017; 88(1):20-23. PubMed ID: 28157250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program.
    Sahlgren H; Elfström KM; Lamin H; Carlsten-Thor A; Eklund C; Dillner J; Elfgren K
    Am J Obstet Gynecol; 2020 Mar; 222(3):253.e1-253.e8. PubMed ID: 31585095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S; Austin RM; Dabbs D; Zhao C
    Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.
    Hildesheim A; Gonzalez P; Kreimer AR; Wacholder S; Schussler J; Rodriguez AC; Porras C; Schiffman M; Sidawy M; Schiller JT; Lowy DR; Herrero R;
    Am J Obstet Gynecol; 2016 Aug; 215(2):212.e1-212.e15. PubMed ID: 26892991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?
    Kabaca C; Giray B; Guray Uzun M; Akis S; Purut YE; Keles Peker E; Cetiner H; Bostanci Ergen E
    Diagn Cytopathol; 2021 Apr; 49(4):480-486. PubMed ID: 33528903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
    Fröberg M; Östensson E; Belkić K; Oštrbenk A; Poljak M; Mints M; Arbyn M; Andersson S
    Cancer; 2019 Jan; 125(2):239-248. PubMed ID: 30536370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-sectional study of anal intraepithelial lesions in women with cervical neoplasia without HIV.
    Heráclio SA; de Souza ASR; de Souza PRE; Katz L; Lima Junior SF; Amorim MMR
    Int J Gynaecol Obstet; 2018 Feb; 140(2):233-240. PubMed ID: 29080327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adeno-associated virus infection and cervical neoplasia: is there a protective role against human papillomavirus-related carcinogenesis?
    Agorastos T; Chrisafi S; Lambropoulos AF; Mikos T; Constandinides TC; Schlehofer JR; Schlehofer B; Kotsis A; Bontis JN
    Eur J Cancer Prev; 2008 Aug; 17(4):364-8. PubMed ID: 18562963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology?
    Smith HJ; Leath CA; Huh WK; Erickson BK
    J Low Genit Tract Dis; 2016 Jul; 20(3):243-6. PubMed ID: 27243140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M; Zhao C
    J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of pathology in women attending colposcopy for postcoital bleeding with negative cytology.
    Sahu B; Latheef R; Aboel Magd S
    Arch Gynecol Obstet; 2007 Nov; 276(5):471-3. PubMed ID: 17429668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2/3 and invasive cervical cancer in Japanese women.
    Azuma Y; Kusumoto-Matsuo R; Takeuchi F; Uenoyama A; Kondo K; Tsunoda H; Nagasaka K; Kawana K; Morisada T; Iwata T; Aoki D; Kukimoto I
    Jpn J Clin Oncol; 2014 Oct; 44(10):910-7. PubMed ID: 25156680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vulvar intraepithelial neoplasia in adolescents with abnormal Pap smear results: a series report.
    Lara-Torre E; Perlman SE
    J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):45-8. PubMed ID: 15010039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
    Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
    Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of VAIN, CIN, and related HPV genotypes in Japanese women with abnormal cytology.
    Zhang S; Saito M; Yamada S; Sakamoto J; Takakura M; Takagi H; Sasagawa T
    J Med Virol; 2020 Mar; 92(3):364-371. PubMed ID: 31642536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of human papilloma virus infection with cytology, colposcopy and histopathological examination of the bioptic tissue in low- and high-grade intraepithelial lesions.
    Jovanović AM; Dikic SD; Jovanovic V; Zamurovic M; Nikolic B; Krsic V; Rakic S; Stanimirovic B
    Eur J Gynaecol Oncol; 2012; 33(5):512-6. PubMed ID: 23185799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.